Clinical study on the efficacy and safety of Huairu Granules combined with chemotherapy and immunotherapy in the conversion treatment of HER2-negative unresectable advanced gastric cancer (ChiCTR) - Oct 16, 2026 - P2 | N=20 | Not yet recruiting | Sponsor: Sichuan Cancer Hospital; Sichuan Cancer Hospital
New P2 trial • Esophageal Cancer • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Oncology • Ovarian Cancer • Solid Tumor • HER-2
|